N-2102

N/A

Report date: 2023/04/27 15:10:55
NME

Base Information

Drug NameN-2102
Drug Alias NameN2102N-2102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyocardial InfarctionAcute Coronary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWisdom Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWisdom Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionAcute Coronary Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A